Adaptive Biotechnologies Corp Insider Trading for February 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Adaptive Biotechnologies Corp.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Adaptive Biotechnologies Corp for February 2020.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 24 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Option Exercise | M | 0.84 | 5,000 | 4,200 | 220,000 | |
| Feb 24 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Option Exercise | M | 0.84 | 80,000 | 67,200 | 225,000 | |
| Feb 24 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 33.55 | 5,000 | 167,750 | 0 | 5 K to 0 (-100.00 %) |
| Feb 24 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Buy | M | 0.84 | 5,000 | 4,200 | 5,000 | 0 to 5 K |
| Feb 24 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 34.01 | 12,200 | 414,922 | 0 | 12.2 K to 0 (-100.00 %) |
| Feb 24 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 33.49 | 67,800 | 2,270,622 | 12,200 | 80 K to 12.2 K (-84.75 %) |
| Feb 24 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Buy | M | 0.84 | 80,000 | 67,200 | 80,000 | 0 to 80 K |
| Feb 24 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Option Exercise | M | 6.32 | 7,400 | 46,768 | 555,600 | |
| Feb 24 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 33.53 | 6,600 | 221,298 | 70,679 | 77.3 K to 70.7 K (-8.54 %) |
| Feb 24 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 32.85 | 800 | 26,280 | 77,279 | 78.1 K to 77.3 K (-1.02 %) |
| Feb 24 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Buy | M | 6.32 | 7,400 | 46,768 | 78,079 | 70.7 K to 78.1 K (+10.47 %) |
| Feb 18 2020 | ADPT | Adaptive Biotechno ... | GRIFFIN MICHELLE RENEE | Director | Option Exercise | A | 31.71 | 8,888 | 281,838 | 8,888 | |
| Feb 18 2020 | ADPT | Adaptive Biotechno ... | NEUPERT PETER M | Director | Option Exercise | A | 31.71 | 8,888 | 281,838 | 8,888 | |
| Feb 18 2020 | ADPT | Adaptive Biotechno ... | Pellini Michael J | Director | Option Exercise | A | 31.71 | 8,888 | 281,838 | 8,888 | |
| Feb 18 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Option Exercise | A | 31.71 | 200,000 | 6,342,000 | 200,000 | |
| Feb 18 2020 | ADPT | Adaptive Biotechno ... | LO FRANCIS | Chief People Office ... | Option Exercise | A | 31.71 | 37,500 | 1,189,125 | 37,500 | |
| Feb 18 2020 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Option Exercise | A | 31.71 | 85,000 | 2,695,350 | 85,000 | |
| Feb 18 2020 | ADPT | Adaptive Biotechno ... | Taylor Stacy L | SVP and General Cou ... | Option Exercise | A | 31.71 | 65,000 | 2,061,150 | 65,000 | |
| Feb 18 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Option Exercise | A | 31.71 | 300,000 | 9,513,000 | 300,000 | |
| Feb 18 2020 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Option Exercise | A | 31.71 | 8,888 | 281,838 | 8,888 | |
| Feb 18 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | SVP, Drug Discovery | Option Exercise | A | 31.71 | 65,000 | 2,061,150 | 65,000 | |
| Feb 18 2020 | ADPT | Adaptive Biotechno ... | ZOLTNERS ANDRIS A | Director | Option Exercise | A | 31.71 | 8,888 | 281,838 | 8,888 | |
| Feb 18 2020 | ADPT | Adaptive Biotechno ... | SANG CHARLES | SVP, Clinical Diagn ... | Option Exercise | A | 31.71 | 40,000 | 1,268,400 | 40,000 | |
| Feb 18 2020 | ADPT | Adaptive Biotechno ... | BALDO LANCE | Chief Medical Offic ... | Option Exercise | A | 31.71 | 37,500 | 1,189,125 | 37,500 | |
| Feb 18 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | A | 31.71 | 300,000 | 9,513,000 | 300,000 | |
| Feb 18 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | M | 0.33 | 11,120 | 3,670 | 713,280 | |
| Feb 18 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 31.56 | 11,120 | 350,947 | 1,878,180 | 1.9 M to 1.9 M (-0.59 %) |
| Feb 18 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Buy | M | 0.33 | 11,120 | 3,670 | 1,889,300 | 1.9 M to 1.9 M (+0.59 %) |
| Feb 18 2020 | ADPT | Adaptive Biotechno ... | HILL NANCY LOUISE | SVP, Operations | Option Exercise | A | 31.71 | 50,000 | 1,585,500 | 50,000 | |
| Feb 18 2020 | ADPT | Adaptive Biotechno ... | Conroy Kevin T | Director | Option Exercise | A | 31.71 | 8,888 | 281,838 | 8,888 | |
| Feb 18 2020 | ADPT | Adaptive Biotechno ... | DOBMEIER ERIC | Director | Option Exercise | A | 31.71 | 8,888 | 281,838 | 8,888 | |
| Feb 12 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | M | 0.33 | 11,120 | 3,670 | 724,000 | |
| Feb 12 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | M | 0.33 | 11,120 | 3,670 | 735,200 | |
| Feb 12 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 31.30 | 11,120 | 348,056 | 1,878,180 | 1.9 M to 1.9 M (-0.59 %) |
| Feb 12 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Buy | M | 0.33 | 11,120 | 3,670 | 1,889,300 | 1.9 M to 1.9 M (+0.59 %) |
| Feb 12 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 31.18 | 11,120 | 346,722 | 1,878,180 | 1.9 M to 1.9 M (-0.59 %) |
| Feb 12 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Buy | M | 0.33 | 11,120 | 3,670 | 1,889,300 | 1.9 M to 1.9 M (+0.59 %) |
| Feb 12 2020 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Option Exercise | M | 4.07 | 20,000 | 81,400 | 60,000 | |
| Feb 12 2020 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Sell | S | 31.44 | 16,721 | 525,708 | 1,000 | 17.7 K to 1,000 (-94.36 %) |
| Feb 12 2020 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Sell | S | 31.90 | 3,279 | 104,600 | 17,721 | 21 K to 17.7 K (-15.61 %) |
| Feb 12 2020 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Buy | M | 4.07 | 20,000 | 81,400 | 21,000 | 1,000 to 21 K (+2,000.00 %) |